There's Good Cause To Be Excited About Amicus Therapeutics Clinical Program
October 04, 2017 at 09:59 AM EDT
Shares of Amicus Therapeutics, Inc. (NASDAQ: FOLD) were trading higher by more than 12 percent Wednesday after the company released ...